LSP-249

CAS No. 1801253-04-2

LSP-249( —— )

Catalog No. M23814 CAS No. 1801253-04-2

LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 36 In Stock
5MG 58 In Stock
10MG 87 In Stock
25MG 177 In Stock
50MG 295 In Stock
100MG 484 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LSP-249
  • Note
    Research use only, not for human use.
  • Brief Description
    LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
  • Description
    LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    kallikrein
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1801253-04-2
  • Formula Weight
    431.92
  • Molecular Formula
    C24H22ClN5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:31.25 mg/mL?(69.45 mM;?ultrasonic and warming and heat to 60°C)
  • SMILES
    Cc1cc(N)nc(C)c1CNC(c1cc(Cc2ccc3ncc(Cl)cc3c2)ncc1)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1.
molnova catalog
related products
  • Iprindole

    Iprindole, a tricyclic indole antidepressant, is a weak inhibitor of the uptake of noradrenaline and 5-HT.

  • Dihydrocatalpol

    Dihydrocatalpol,a natural product obtained from the herbs of Rehmannia glutinosa.

  • PBIT

    PBIT inhibits JARID1B histone demethylase (IC50 of about 3 μM). PBIT also inhibits JARID1A and JARID1C (IC50s of 6 μM and 4.9 μM, respectively). PBIT is a specific inhibitor of the Jumonji AT-rich Interactive Domain 1 (JARID1) enzymes . PBIT, which inhibits JARID1B with an IC50 of about 3 μm in vitro.